NeuroStar Expands “Tap Into Possibility” Campaign in Honor of Mental Health Awareness Month

Campaign features patients’ experiences to support others with depression

Neuronetics, Inc., a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the evolution of its "Tap Into Possibility" campaign. This year, the campaign will focus on the journey of several patients who have overcome depression and their path to recovery through NeuroStar Advanced Therapy.

“The patient journey is at the heart of everything we do. We understand that depression can be debilitating, and we want to be part of the solution,” said Keith J. Sullivan, President and CEO of Neuronetics. “The evolution of this campaign was based on the input of our advocate group and the concept that for depressed people, even hope is sometimes too much to hope for, but possibility is what they’re looking for. By sharing stories of patients who have undergone treatment with NeuroStar TMS, we hope to inspire others to seek help and tap into their own possibilities.”

The “Tap Into Possibility” campaign first launched in 2022 to raise awareness about the impact of major depressive disorder (MDD) on millions of people and the possibilities for patients after trying multiple treatment options to no avail. 

 "The truth is, I am enough. I am worth it, and I am worthy. As cliche as it sounds, NeuroStar has completely changed my life. I am a different person. I found me. I found a better version of myself. I found love that I didn't know existed. It's been an incredible journey, and I am forever grateful. Because I know the alternative is much worse." – Cara . I've had a lot of different cocktails of medications over the past 15 years. They would work for a little while, and then I would go back into a depressive episode. NeuroStar has impacted every single aspect of my life. I can live my life again because of this treatment." - Jess

The campaign featuring inspiring narratives from patient advocates will launch in May and extend throughout the year across owned channels and NeuroStar's website. 

Published on : 10th May, 2023